Z79.811 Billable / specific Long term (current) use of aromatase inhibitors

ICD-10-CM Z79.811 identifies “Long term (current) use of aromatase inhibitors” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 21: Factors influencing health status and contact with health services

Exempt from present-on-admission reporting

Code-level instructions

Inclusion terms3
  • Long term (current) use of anastrozole (Arimidex)
  • Long term (current) use of exemestane (Aromasin)
  • Long term (current) use of letrozole (Femara)

Inherited instructions

Z79.81 · Long term (current) use of agents affecting estrogen receptors and estrogen levels

Excludes 11

hormone replacement therapy (Z79.890)

Code first3
  • , if applicable:
  • malignant neoplasm of breast (C50.-)
  • malignant neoplasm of prostate (C61)
Use additional code7
  • code, if applicable, to identify:
  • estrogen receptor positive status (Z17.0)
  • family history of breast cancer (Z80.3)
  • genetic susceptibility to malignant neoplasm (cancer) (Z15.0-)
  • personal history of breast cancer (Z85.3)
  • personal history of prostate cancer (Z85.46)
  • postmenopausal status (Z78.0)

Chapters 21 · Factors influencing health status and contact with health services (Z00-Z99)

Note3
  • Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
  • (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
  • (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.

Z77-Z99 · Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99)

Code also1

any follow-up examination (Z08-Z09)

Z79 · Long term (current) drug therapy

Includes1

long term (current) drug use for prophylactic purposes

Excludes 22
  • drug abuse and dependence (F11-F19)
  • drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)
Code also1

any therapeutic drug level monitoring (Z51.81)

Official index references

Official index references (8)

Long-term(current) (prophylactic) drug therapy (use of) (4)
Therapy (4)
History

Code history

Latest recorded change · FY2021

ChangedUnchanged
FY2021

Effective from

  • Inherited rules changed

Long term (current) use of aromatase inhibitors

Billable diagnosis code

CDC/NCHS · FY2021

All editions (19)

All editionsEffective fromCode history
FY20162015-10-01First observed
FY20172016-10-01Inherited rules changed
FY20182017-10-01Inherited rules changed
FY20192018-10-01No tabular change
FY20202019-10-01No tabular change
FY2020 · April2020-04-01No tabular change
FY20212020-10-01Inherited rules changed
FY2021 · 01-012021-01-01No tabular change
FY20222021-10-01No tabular change
FY2022 · 04-012022-04-01No tabular change
FY20232022-10-01No tabular change
FY2023 · 04-012023-04-01No tabular change
FY20242023-10-01No tabular change
FY2024 · 04-012024-04-01No tabular change
FY20252024-10-01No tabular change
FY2025 · 04-012025-04-01No tabular change
FY20262025-10-01No tabular change
FY2026 · April2026-04-01No tabular change
FY20272026-10-01No tabular change
Historical ICD-9 mappings · 2018

Historical mapping only; not an automatic code substitution.

  • V07.52

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.